Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.27590191 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.13921101 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.10520642 |
4 | negative regulation of cell killing (GO:0031342) | 6.10520642 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.05608031 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.05608031 |
7 | modulation by symbiont of host immune response (GO:0052553) | 6.05608031 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 6.05608031 |
9 | modulation by symbiont of host defense response (GO:0052031) | 6.05608031 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.05608031 |
11 | neutrophil activation involved in immune response (GO:0002283) | 5.86455392 |
12 | response to peptidoglycan (GO:0032494) | 5.46976237 |
13 | macrophage activation involved in immune response (GO:0002281) | 5.12899849 |
14 | * detection of other organism (GO:0098543) | 5.12255796 |
15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.94862928 |
16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.94121624 |
17 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 4.82600801 |
18 | * detection of bacterium (GO:0016045) | 4.77557881 |
19 | cellular extravasation (GO:0045123) | 4.52947351 |
20 | detection of molecule of bacterial origin (GO:0032490) | 4.49339829 |
21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.48558516 |
22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.46748363 |
23 | negative regulation of interleukin-12 production (GO:0032695) | 4.43934540 |
24 | leukocyte aggregation (GO:0070486) | 4.37458643 |
25 | immunoglobulin mediated immune response (GO:0016064) | 4.36185163 |
26 | * detection of external biotic stimulus (GO:0098581) | 4.30869291 |
27 | microglial cell activation (GO:0001774) | 4.27705697 |
28 | respiratory burst (GO:0045730) | 4.23751608 |
29 | positive regulation of mast cell activation (GO:0033005) | 4.23155278 |
30 | regulation of mast cell degranulation (GO:0043304) | 4.21263374 |
31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.20072270 |
32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.18164533 |
33 | neutrophil activation (GO:0042119) | 4.16816263 |
34 | response to host immune response (GO:0052572) | 4.01924597 |
35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.01924597 |
36 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.01036184 |
37 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.98269962 |
38 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.90867001 |
39 | * detection of biotic stimulus (GO:0009595) | 3.89480688 |
40 | myeloid cell activation involved in immune response (GO:0002275) | 3.88708074 |
41 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.88297859 |
42 | macrophage activation (GO:0042116) | 3.87171379 |
43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.81620324 |
44 | regulation of mast cell activation (GO:0033003) | 3.81146099 |
45 | response to muramyl dipeptide (GO:0032495) | 3.76726234 |
46 | neutrophil mediated immunity (GO:0002446) | 3.76088327 |
47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.75682097 |
48 | granulocyte activation (GO:0036230) | 3.74305909 |
49 | positive regulation of mast cell degranulation (GO:0043306) | 3.73326702 |
50 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.73326702 |
51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.72507705 |
52 | regulation of leukocyte degranulation (GO:0043300) | 3.72021662 |
53 | response to host (GO:0075136) | 3.70856309 |
54 | response to host defenses (GO:0052200) | 3.70856309 |
55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.70856309 |
56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.69954487 |
57 | B cell receptor signaling pathway (GO:0050853) | 3.64009443 |
58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.57668335 |
59 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57319544 |
60 | regulation of tolerance induction (GO:0002643) | 3.52846173 |
61 | positive regulation of B cell differentiation (GO:0045579) | 3.52220203 |
62 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.49788926 |
63 | B cell mediated immunity (GO:0019724) | 3.43502464 |
64 | regulation of B cell differentiation (GO:0045577) | 3.42564202 |
65 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.40385018 |
66 | positive thymic T cell selection (GO:0045059) | 3.37014929 |
67 | regulation of T cell tolerance induction (GO:0002664) | 3.33414341 |
68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.26670354 |
69 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.21569287 |
70 | negative regulation of phagocytosis (GO:0050765) | 3.21437293 |
71 | regulation of regulated secretory pathway (GO:1903305) | 3.20763522 |
72 | myeloid leukocyte mediated immunity (GO:0002444) | 3.20640301 |
73 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.19410567 |
74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19123043 |
75 | leukocyte degranulation (GO:0043299) | 3.15462716 |
76 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.14407234 |
77 | negative thymic T cell selection (GO:0045060) | 3.14348180 |
78 | activated T cell proliferation (GO:0050798) | 3.11559297 |
79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.08703364 |
80 | defense response to protozoan (GO:0042832) | 3.08250428 |
81 | negative T cell selection (GO:0043383) | 3.08025782 |
82 | regulation of antigen processing and presentation (GO:0002577) | 3.07876622 |
83 | response to interleukin-15 (GO:0070672) | 3.06837622 |
84 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.05740502 |
85 | dendritic cell migration (GO:0036336) | 2.99461009 |
86 | positive regulation of antigen processing and presentation (GO:0002579) | 2.97293339 |
87 | type I interferon signaling pathway (GO:0060337) | 2.94996776 |
88 | cellular response to type I interferon (GO:0071357) | 2.94996776 |
89 | positive regulation of tolerance induction (GO:0002645) | 2.92802993 |
90 | response to type I interferon (GO:0034340) | 2.91575315 |
91 | myeloid leukocyte activation (GO:0002274) | 2.88868234 |
92 | regulation of macrophage cytokine production (GO:0010935) | 2.88081620 |
93 | negative regulation of innate immune response (GO:0045824) | 2.87793786 |
94 | positive regulation of interferon-alpha production (GO:0032727) | 2.86966432 |
95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86305526 |
96 | positive T cell selection (GO:0043368) | 2.86212739 |
97 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86192333 |
98 | T cell migration (GO:0072678) | 2.85849475 |
99 | dendritic cell chemotaxis (GO:0002407) | 2.84754455 |
100 | negative regulation of interleukin-6 production (GO:0032715) | 2.82414996 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.80835559 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.60558933 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.31950661 |
4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.80004935 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.51846271 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.49695425 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.43029842 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.40741372 |
9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03766944 |
10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.02414373 |
11 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.95331120 |
12 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.93315787 |
13 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.83255702 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.83192090 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63274741 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.62431354 |
17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.60136593 |
18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.55569739 |
19 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48451120 |
20 | MAF_26560356_Chip-Seq_TH1_Human | 2.35234789 |
21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34009373 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.32813702 |
23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.30952977 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.30839834 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27735743 |
26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27397800 |
27 | MYC_22102868_ChIP-Seq_BL_Human | 2.24114234 |
28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.20126856 |
29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19339157 |
30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.17285985 |
31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13410141 |
32 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12668534 |
33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.09920436 |
34 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07662177 |
35 | MYB_26560356_Chip-Seq_TH1_Human | 2.02805811 |
36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98074533 |
37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89595040 |
38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83187548 |
39 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.80754500 |
40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77070624 |
41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73754873 |
42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69127075 |
43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65626274 |
44 | MAF_26560356_Chip-Seq_TH2_Human | 1.62472083 |
45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60897914 |
46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58760179 |
47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57174248 |
48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55702191 |
49 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.53179308 |
50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.51978377 |
51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47160168 |
52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45987396 |
53 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44513165 |
54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43982773 |
55 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43037415 |
56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42719014 |
57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41843672 |
58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41033546 |
59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40514321 |
60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39806831 |
61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37054935 |
62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35691413 |
63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34585482 |
64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34473949 |
65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33295931 |
66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32417499 |
67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31034580 |
68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28416245 |
69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28404872 |
70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25282732 |
71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20781409 |
72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20765749 |
73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18720499 |
74 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11917719 |
75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11832109 |
76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11094605 |
77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09742428 |
78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09390908 |
79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07828785 |
80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05200287 |
81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04239337 |
82 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03935858 |
83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98486758 |
84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97192803 |
85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97157234 |
86 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94706735 |
87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93265830 |
88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90861966 |
89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90475557 |
90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89257204 |
91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88236763 |
92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87414644 |
93 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87400168 |
94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87009791 |
95 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86340512 |
96 | GATA1_22025678_ChIP-Seq_K562_Human | 0.86094916 |
97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80378305 |
98 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79754220 |
99 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.79518846 |
100 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.78087078 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.58886958 |
2 | MP0001835_abnormal_antigen_presentation | 4.15971544 |
3 | MP0003436_decreased_susceptibility_to | 4.14706967 |
4 | MP0003303_peritoneal_inflammation | 3.42158602 |
5 | MP0002419_abnormal_innate_immunity | 3.17714484 |
6 | MP0001800_abnormal_humoral_immune | 2.97612631 |
7 | MP0005671_abnormal_response_to | 2.97254315 |
8 | MP0000685_abnormal_immune_system | 2.93697503 |
9 | MP0005025_abnormal_response_to | 2.88643593 |
10 | MP0001790_abnormal_immune_system | 2.82058254 |
11 | MP0005387_immune_system_phenotype | 2.82058254 |
12 | MP0009785_altered_susceptibility_to | 2.80154332 |
13 | MP0005000_abnormal_immune_tolerance | 2.78963817 |
14 | MP0006082_CNS_inflammation | 2.76437149 |
15 | MP0002723_abnormal_immune_serum | 2.54590695 |
16 | MP0002452_abnormal_antigen_presenting | 2.53459701 |
17 | MP0002420_abnormal_adaptive_immunity | 2.50328170 |
18 | MP0001819_abnormal_immune_cell | 2.47434167 |
19 | MP0003300_gastrointestinal_ulcer | 2.25269592 |
20 | MP0008260_abnormal_autophagy | 2.23887157 |
21 | MP0003191_abnormal_cellular_cholesterol | 2.21184785 |
22 | MP0003828_pulmonary_edema | 2.17678203 |
23 | MP0002148_abnormal_hypersensitivity_rea | 2.16470636 |
24 | MP0005464_abnormal_platelet_physiology | 2.16237850 |
25 | MP0001533_abnormal_skeleton_physiology | 2.07347292 |
26 | MP0003763_abnormal_thymus_physiology | 2.05360307 |
27 | MP0003172_abnormal_lysosome_physiology | 2.01303792 |
28 | MP0002132_abnormal_respiratory_system | 1.92838650 |
29 | MP0010155_abnormal_intestine_physiology | 1.92767608 |
30 | MP0002398_abnormal_bone_marrow | 1.87827882 |
31 | MP0000716_abnormal_immune_system | 1.85722100 |
32 | MP0002405_respiratory_system_inflammati | 1.79671353 |
33 | MP0001845_abnormal_inflammatory_respons | 1.79173396 |
34 | MP0003183_abnormal_peptide_metabolism | 1.69184790 |
35 | MP0009278_abnormal_bone_marrow | 1.69124982 |
36 | MP0000689_abnormal_spleen_morphology | 1.62693861 |
37 | MP0000465_gastrointestinal_hemorrhage | 1.62176412 |
38 | MP0004947_skin_inflammation | 1.59325371 |
39 | MP0002722_abnormal_immune_system | 1.56611774 |
40 | MP0002166_altered_tumor_susceptibility | 1.53628149 |
41 | MP0003866_abnormal_defecation | 1.51958878 |
42 | MP0009333_abnormal_splenocyte_physiolog | 1.50022909 |
43 | MP0004883_abnormal_blood_vessel | 1.48018984 |
44 | MP0008469_abnormal_protein_level | 1.47846487 |
45 | MP0002429_abnormal_blood_cell | 1.46916822 |
46 | MP0005058_abnormal_lysosome_morphology | 1.45983757 |
47 | MP0001851_eye_inflammation | 1.43381373 |
48 | MP0000858_altered_metastatic_potential | 1.39648996 |
49 | MP0009764_decreased_sensitivity_to | 1.39193972 |
50 | MP0002396_abnormal_hematopoietic_system | 1.38776092 |
51 | MP0005397_hematopoietic_system_phenotyp | 1.31225251 |
52 | MP0001545_abnormal_hematopoietic_system | 1.31225251 |
53 | MP0002138_abnormal_hepatobiliary_system | 1.29966519 |
54 | MP0000703_abnormal_thymus_morphology | 1.29519843 |
55 | MP0002009_preneoplasia | 1.27260566 |
56 | MP0005451_abnormal_body_composition | 1.26390277 |
57 | MP0002998_abnormal_bone_remodeling | 1.25410518 |
58 | MP0005310_abnormal_salivary_gland | 1.25071245 |
59 | MP0004381_abnormal_hair_follicle | 1.24692185 |
60 | MP0008004_abnormal_stomach_pH | 1.24478615 |
61 | MP0003075_altered_response_to | 1.22208378 |
62 | MP0005166_decreased_susceptibility_to | 1.18388533 |
63 | MP0003690_abnormal_glial_cell | 1.17869548 |
64 | MP0004510_myositis | 1.16539758 |
65 | MP0003806_abnormal_nucleotide_metabolis | 1.15380322 |
66 | MP0001853_heart_inflammation | 1.11864226 |
67 | MP0005164_abnormal_response_to | 1.02085729 |
68 | MP0001986_abnormal_taste_sensitivity | 0.95402686 |
69 | MP0002277_abnormal_respiratory_mucosa | 0.94859173 |
70 | MP0005360_urolithiasis | 0.94811920 |
71 | MP0009763_increased_sensitivity_to | 0.89417586 |
72 | MP0002006_tumorigenesis | 0.87312720 |
73 | MP0005085_abnormal_gallbladder_physiolo | 0.86499570 |
74 | MP0003448_altered_tumor_morphology | 0.85929763 |
75 | MP0000604_amyloidosis | 0.85662382 |
76 | MP0001663_abnormal_digestive_system | 0.85390335 |
77 | MP0005075_abnormal_melanosome_morpholog | 0.84904085 |
78 | MP0001873_stomach_inflammation | 0.82084324 |
79 | MP0005390_skeleton_phenotype | 0.81933123 |
80 | MP0000490_abnormal_crypts_of | 0.80461002 |
81 | MP0000343_altered_response_to | 0.77739268 |
82 | MP0003252_abnormal_bile_duct | 0.76160147 |
83 | MP0005365_abnormal_bile_salt | 0.72344333 |
84 | MP0000249_abnormal_blood_vessel | 0.71402914 |
85 | MP0002933_joint_inflammation | 0.66532644 |
86 | MP0004808_abnormal_hematopoietic_stem | 0.65040459 |
87 | MP0000015_abnormal_ear_pigmentation | 0.63018349 |
88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62397588 |
89 | MP0003795_abnormal_bone_structure | 0.62247684 |
90 | MP0005388_respiratory_system_phenotype | 0.60432885 |
91 | MP0002133_abnormal_respiratory_system | 0.60432885 |
92 | MP0005076_abnormal_cell_differentiation | 0.59252143 |
93 | MP0005319_abnormal_enzyme/_coenzyme | 0.58786851 |
94 | MP0009765_abnormal_xenobiotic_induced | 0.57238005 |
95 | MP0008874_decreased_physiological_sensi | 0.56761465 |
96 | MP0003656_abnormal_erythrocyte_physiolo | 0.54588227 |
97 | MP0000609_abnormal_liver_physiology | 0.54297207 |
98 | MP0003091_abnormal_cell_migration | 0.53580323 |
99 | MP0004264_abnormal_extraembryonic_tissu | 0.52781793 |
100 | MP0005376_homeostasis/metabolism_phenot | 0.51202516 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.71304793 |
2 | Recurrent abscess formation (HP:0002722) | 6.33738893 |
3 | Recurrent bacterial skin infections (HP:0005406) | 6.29284931 |
4 | Abnormality of macrophages (HP:0004311) | 5.58663655 |
5 | Myositis (HP:0100614) | 5.50605253 |
6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.50507697 |
7 | Orchitis (HP:0100796) | 5.09809435 |
8 | Retrobulbar optic neuritis (HP:0100654) | 4.88777485 |
9 | Optic neuritis (HP:0100653) | 4.88777485 |
10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.71580588 |
11 | Stomatitis (HP:0010280) | 4.59851869 |
12 | Recurrent fungal infections (HP:0002841) | 4.30909094 |
13 | Recurrent skin infections (HP:0001581) | 4.27092941 |
14 | Gastrointestinal infarctions (HP:0005244) | 4.20646010 |
15 | Meningitis (HP:0001287) | 4.18561918 |
16 | Obstructive lung disease (HP:0006536) | 4.07466308 |
17 | Chronic obstructive pulmonary disease (HP:0006510) | 4.07466308 |
18 | Mediastinal lymphadenopathy (HP:0100721) | 4.06654458 |
19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.90386606 |
20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.90386606 |
21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.80602161 |
22 | Encephalitis (HP:0002383) | 3.73817191 |
23 | Amyloidosis (HP:0011034) | 3.60457449 |
24 | Keratoconjunctivitis sicca (HP:0001097) | 3.59576511 |
25 | Gingivitis (HP:0000230) | 3.59090945 |
26 | Vasculitis (HP:0002633) | 3.55922386 |
27 | Urticaria (HP:0001025) | 3.50064598 |
28 | Spontaneous hematomas (HP:0007420) | 3.48362561 |
29 | Prolonged bleeding time (HP:0003010) | 3.33831612 |
30 | Keratoconjunctivitis (HP:0001096) | 3.29271674 |
31 | Cellulitis (HP:0100658) | 3.22467494 |
32 | Increased IgE level (HP:0003212) | 3.19277203 |
33 | Gingival bleeding (HP:0000225) | 3.16723723 |
34 | Chest pain (HP:0100749) | 3.16649335 |
35 | Hemoptysis (HP:0002105) | 3.14701108 |
36 | Recurrent viral infections (HP:0004429) | 3.12568791 |
37 | Episodic fever (HP:0001954) | 3.09303435 |
38 | Pulmonary infiltrates (HP:0002113) | 3.01203101 |
39 | Inflammation of the large intestine (HP:0002037) | 2.88629307 |
40 | Epistaxis (HP:0000421) | 2.87283490 |
41 | Leukocytosis (HP:0001974) | 2.86994023 |
42 | Arterial thrombosis (HP:0004420) | 2.86888025 |
43 | Panhypogammaglobulinemia (HP:0003139) | 2.82663974 |
44 | Pulmonary embolism (HP:0002204) | 2.82049233 |
45 | Peritonitis (HP:0002586) | 2.81931532 |
46 | Gastrointestinal inflammation (HP:0004386) | 2.79913069 |
47 | T lymphocytopenia (HP:0005403) | 2.76167914 |
48 | Osteomyelitis (HP:0002754) | 2.74128258 |
49 | Anorexia (HP:0002039) | 2.72455821 |
50 | Petechiae (HP:0000967) | 2.67485774 |
51 | Abnormality of T cell number (HP:0011839) | 2.65138813 |
52 | Increased cerebral lipofuscin (HP:0011813) | 2.58680214 |
53 | Colitis (HP:0002583) | 2.58504819 |
54 | Hypochromic anemia (HP:0001931) | 2.57946847 |
55 | Hypochromic microcytic anemia (HP:0004840) | 2.57834714 |
56 | Agammaglobulinemia (HP:0004432) | 2.55752922 |
57 | Pustule (HP:0200039) | 2.55711575 |
58 | Malnutrition (HP:0004395) | 2.47996478 |
59 | Purpura (HP:0000979) | 2.46170691 |
60 | Gangrene (HP:0100758) | 2.41329357 |
61 | Abnormality of T cells (HP:0002843) | 2.40879903 |
62 | Granulocytopenia (HP:0001913) | 2.35031035 |
63 | Lymphopenia (HP:0001888) | 2.34970465 |
64 | Systemic lupus erythematosus (HP:0002725) | 2.34514078 |
65 | Abnormality of the pleura (HP:0002103) | 2.31684039 |
66 | Sepsis (HP:0100806) | 2.29226307 |
67 | Increased IgM level (HP:0003496) | 2.27672792 |
68 | Increased serum ferritin (HP:0003281) | 2.22058010 |
69 | Abnormal platelet volume (HP:0011876) | 2.19299166 |
70 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.17916301 |
71 | Abnormality of the peritoneum (HP:0002585) | 2.15692999 |
72 | Skin ulcer (HP:0200042) | 2.14504026 |
73 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14255587 |
74 | Abnormality of T cell physiology (HP:0011840) | 2.11216259 |
75 | Skin rash (HP:0000988) | 2.10337781 |
76 | Recurrent pneumonia (HP:0006532) | 2.08531209 |
77 | Loss of speech (HP:0002371) | 2.05746270 |
78 | Acute hepatic failure (HP:0006554) | 2.05234145 |
79 | Glomerulopathy (HP:0100820) | 2.04971391 |
80 | Vertigo (HP:0002321) | 2.03840051 |
81 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03169762 |
82 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03169762 |
83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03169762 |
84 | Abnormality of iron homeostasis (HP:0011031) | 2.02431478 |
85 | Hepatosplenomegaly (HP:0001433) | 2.00613917 |
86 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99584323 |
87 | Thrombophlebitis (HP:0004418) | 1.98509224 |
88 | Abnormality of the endocardium (HP:0004306) | 1.97467413 |
89 | Amaurosis fugax (HP:0100576) | 1.95275672 |
90 | Hypergammaglobulinemia (HP:0010702) | 1.94883579 |
91 | Eosinophilia (HP:0001880) | 1.94713203 |
92 | Microcytic anemia (HP:0001935) | 1.94704244 |
93 | Polyneuropathy (HP:0001271) | 1.94436969 |
94 | IgM deficiency (HP:0002850) | 1.91795303 |
95 | Viral hepatitis (HP:0006562) | 1.90134155 |
96 | Recurrent lower respiratory tract infections (HP:0002783) | 1.88647793 |
97 | Cheilitis (HP:0100825) | 1.86315623 |
98 | Gastrointestinal stroma tumor (HP:0100723) | 1.85726003 |
99 | Papilloma (HP:0012740) | 1.83742967 |
100 | Verrucae (HP:0200043) | 1.83742967 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 5.30733900 |
2 | BLK | 3.75134821 |
3 | MAP4K1 | 3.37992988 |
4 | TYK2 | 3.14514833 |
5 | MAP2K3 | 3.08775837 |
6 | PRPF4B | 2.79553776 |
7 | FES | 2.79486323 |
8 | IRAK4 | 2.77849571 |
9 | CSK | 2.73411388 |
10 | ERN1 | 2.63212863 |
11 | ZAP70 | 2.19215824 |
12 | GRK6 | 2.16027026 |
13 | TNK2 | 2.10712282 |
14 | FGR | 1.99011204 |
15 | BTK | 1.98022923 |
16 | MAP3K3 | 1.91515192 |
17 | SYK | 1.91038751 |
18 | MAP3K14 | 1.80974117 |
19 | JAK3 | 1.80762222 |
20 | MAP3K13 | 1.74897771 |
21 | HCK | 1.71456780 |
22 | TXK | 1.52784720 |
23 | TAOK1 | 1.50727602 |
24 | CSF1R | 1.49462872 |
25 | LYN | 1.44439427 |
26 | IKBKE | 1.43803090 |
27 | JAK1 | 1.40213607 |
28 | EPHB1 | 1.37861508 |
29 | JAK2 | 1.37057263 |
30 | SIK3 | 1.34648242 |
31 | TBK1 | 1.33216868 |
32 | KIT | 1.32147961 |
33 | MAP3K11 | 1.31102341 |
34 | TEC | 1.30551286 |
35 | MAP3K1 | 1.29440842 |
36 | YES1 | 1.28879656 |
37 | BMPR2 | 1.26936695 |
38 | CDK19 | 1.26233417 |
39 | LCK | 1.15628355 |
40 | ITK | 1.15040725 |
41 | KSR2 | 1.14717678 |
42 | STK10 | 1.09894650 |
43 | IRAK2 | 1.05219227 |
44 | PIK3CG | 0.96642304 |
45 | TGFBR2 | 0.96600628 |
46 | PDK1 | 0.95337097 |
47 | MARK3 | 0.95147534 |
48 | TAOK3 | 0.93780821 |
49 | MARK2 | 0.90457055 |
50 | MATK | 0.90264629 |
51 | IRAK1 | 0.88872937 |
52 | PDPK1 | 0.86423614 |
53 | LRRK2 | 0.82704350 |
54 | MAP3K6 | 0.82333139 |
55 | MAPK12 | 0.81886170 |
56 | MAPK7 | 0.80449950 |
57 | IKBKB | 0.79400947 |
58 | PTK6 | 0.77398310 |
59 | FYN | 0.68009805 |
60 | TRIB3 | 0.67690796 |
61 | PRKD2 | 0.67222334 |
62 | TAOK2 | 0.65695822 |
63 | MAP3K7 | 0.64986779 |
64 | MAP3K2 | 0.61905242 |
65 | SIK2 | 0.60332534 |
66 | DYRK1B | 0.58808611 |
67 | TESK2 | 0.56388255 |
68 | PRKCQ | 0.56351796 |
69 | CDK6 | 0.54308317 |
70 | CDC42BPA | 0.54092732 |
71 | MAP3K5 | 0.52081335 |
72 | MAP2K4 | 0.51856616 |
73 | SGK3 | 0.49238689 |
74 | FGFR3 | 0.47059180 |
75 | MOS | 0.46752819 |
76 | NLK | 0.45468071 |
77 | STK11 | 0.44964595 |
78 | MAP3K10 | 0.43606154 |
79 | SMG1 | 0.42683059 |
80 | RPS6KC1 | 0.41472231 |
81 | RPS6KL1 | 0.41472231 |
82 | PTK2B | 0.40986685 |
83 | PIM1 | 0.39526221 |
84 | MAP3K8 | 0.36774113 |
85 | MAPKAPK2 | 0.36058071 |
86 | CDK4 | 0.33900533 |
87 | RAF1 | 0.33505387 |
88 | RET | 0.33415438 |
89 | RPS6KA6 | 0.32163431 |
90 | FGFR4 | 0.32055200 |
91 | MAP2K2 | 0.31177706 |
92 | HIPK2 | 0.31111340 |
93 | PRKG2 | 0.30957102 |
94 | SGK2 | 0.30760497 |
95 | SIK1 | 0.30054303 |
96 | KSR1 | 0.29921770 |
97 | ACVR1B | 0.29463364 |
98 | GRK7 | 0.28272302 |
99 | ABL1 | 0.28029137 |
100 | PRKD1 | 0.27989426 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.37664145 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.36831926 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.05998735 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.73115054 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70128448 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.57008564 |
7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.41106538 |
8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.35549558 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.29253003 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.13683781 |
11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.12392487 |
12 | Asthma_Homo sapiens_hsa05310 | 2.11273812 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04243410 |
14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.01031390 |
15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98053570 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94938115 |
17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.94318095 |
18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89423209 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.88766603 |
20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79163098 |
21 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68851899 |
22 | Malaria_Homo sapiens_hsa05144 | 1.66093850 |
23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65930189 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63119926 |
25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.60317745 |
26 | Legionellosis_Homo sapiens_hsa05134 | 1.58955682 |
27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.56673624 |
28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.52037064 |
29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.51996107 |
30 | Influenza A_Homo sapiens_hsa05164 | 1.51479827 |
31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50928658 |
32 | Measles_Homo sapiens_hsa05162 | 1.50719346 |
33 | Phagosome_Homo sapiens_hsa04145 | 1.47673916 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38302013 |
35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25084478 |
36 | Pertussis_Homo sapiens_hsa05133 | 1.22697091 |
37 | Platelet activation_Homo sapiens_hsa04611 | 1.17896147 |
38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15289050 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14476629 |
40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10367673 |
41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.08489487 |
42 | Hepatitis B_Homo sapiens_hsa05161 | 1.05417515 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04578804 |
44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03941447 |
45 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96817362 |
46 | Shigellosis_Homo sapiens_hsa05131 | 0.91765204 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 0.91291066 |
48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87216683 |
49 | Hepatitis C_Homo sapiens_hsa05160 | 0.82780195 |
50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80751705 |
51 | Lysosome_Homo sapiens_hsa04142 | 0.78065494 |
52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76238636 |
53 | Apoptosis_Homo sapiens_hsa04210 | 0.74187468 |
54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73544511 |
55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71849317 |
56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71580522 |
57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69900542 |
58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69514520 |
59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66943675 |
60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65287600 |
61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65079736 |
62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64128841 |
63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63035072 |
64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62504855 |
65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62082959 |
66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60835558 |
67 | Endocytosis_Homo sapiens_hsa04144 | 0.60485689 |
68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59887269 |
69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58720127 |
70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56635392 |
71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55980812 |
72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55949950 |
73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55907692 |
74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55280041 |
75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54522687 |
76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53377165 |
77 | * Amoebiasis_Homo sapiens_hsa05146 | 0.53128872 |
78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52857077 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51946838 |
80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51519995 |
81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49523359 |
82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47947030 |
83 | Insulin resistance_Homo sapiens_hsa04931 | 0.47113060 |
84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46637378 |
85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44358818 |
86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43454359 |
87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43279978 |
88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42651298 |
89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42205802 |
90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40376914 |
91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39789474 |
92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34283420 |
93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34249326 |
94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34163608 |
95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33331503 |
96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28485091 |
97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27905120 |
98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27744441 |
99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27701945 |
100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27077387 |